COVID-19: India gets vaccine as DCGI approves Serum, Bharat Biotech vaccines for emergency use
Highlights Covaxin is developed by Bharat Biotech. Serum Intitute and Bharat Biotech vaccines have to be administered in two doses. In a significant development, Drugs Controller General of India (DCGI) on Sunday (January 3) formally approved Serum Institute's Covishield and Bharat Biotech's Covaxin for restricted use in India. "Serum Intitute and Bharat Biotech vaccines have to be administered in two doses. All the three vaccines have to be stored at 2-8° C. After adequate examination, CDSCO has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of M/s...